Literature DB >> 19706709

Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.

Silvia Geuenich1, Lars Kaderali, Ina Allespach, Serkan Sertel, Oliver T Keppler.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) group M viruses have achieved a global distribution, while HIV-1 group O viruses are endemic only in particular regions of Africa. Here, we evaluated biological characteristics of group O and group M viruses in ex vivo models of HIV-1 infection. The replicative capacity and ability to induce CD4 T-cell depletion of eight group O and seven group M primary isolates were monitored in cultures of human peripheral blood mononuclear cells and tonsil explants. Comparative and longitudinal infection studies revealed HIV-1 group-specific activity patterns: CCR5-using (R5) viruses from group M varied considerably in their replicative capacity but showed similar levels of cytopathicity. In contrast, R5 isolates from group O were relatively uniform in their replicative fitness but displayed a high and unprecedented variability in their potential to deplete CD4 T cells. Two R5 group O isolates were identified that cause massive depletion of CD4 T cells, to an extent comparable to CXCR4-using viruses and not documented for any R5 isolate from group M. Intergroup comparisons found a five- to eightfold lower replicative fitness of isolates from group O than for isolates from group M yet a similar overall intrinsic pathogenicity in tonsil cultures. This study establishes biological ex vivo characteristics of HIV-1 group O primary isolates. The current findings challenge the belief that a grossly reduced replicative fitness or inherently impaired cytopathicity of viruses from this group underlies their low global prevalence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706709      PMCID: PMC2753123          DOI: 10.1128/JVI.00928-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  The molecular clock of HIV-1 unveiled through analysis of a known transmission history.

Authors:  T Leitner; J Albert
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

Authors:  S Glushakova; Y Yi; J C Grivel; A Singh; D Schols; E De Clercq; R G Collman; L Margolis
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

3.  T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells.

Authors:  Thomas Neumann; Isabel Hagmann; Sabine Lohrengel; Marintha L Heil; Cynthia A Derdeyn; Hans-Georg Kräusslich; Matthias T Dittmar
Journal:  Virology       Date:  2005-03-15       Impact factor: 3.616

4.  CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.

Authors:  M L Penn; J C Grivel; B Schramm; M A Goldsmith; L Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

5.  Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s.

Authors:  T O Jonassen; K Stene-Johansen; E S Berg; O Hungnes; C F Lindboe; S S Frøland; B Grinde
Journal:  Virology       Date:  1997-04-28       Impact factor: 3.616

6.  Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef.

Authors:  Oliver T Keppler; Ina Allespach; Lismarie Schüller; David Fenard; Warner C Greene; Oliver T Fackler
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1.

Authors:  Prerana Jayakumar; Irina Berger; Frank Autschbach; Mark Weinstein; Benjamin Funke; Eric Verdin; Mark A Goldsmith; Oliver T Keppler
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.

Authors:  J C Grivel; L B Margolis
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

9.  Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.

Authors:  O T Keppler; W Yonemoto; F J Welte; K S Patton; D Iacovides; R E Atchison; T Ngo; D L Hirschberg; R F Speck; M A Goldsmith
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency.

Authors:  S Glushakova; J C Grivel; W Fitzgerald; A Sylwester; J Zimmerberg; L B Margolis
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

View more
  4 in total

Review 1.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Analytical Advances in the Ex Vivo Challenge Efficacy Assay.

Authors:  Nicola Richardson-Harman; Robert Parody; Peter Anton; Ian McGowan; Gustavo Doncel; Andrea Ries Thurman; Carolina Herrera; Kattayoun Kordy; Julie Fox; Karen Tanner; Glenn Swartz; Charlene S Dezzutti
Journal:  AIDS Res Hum Retroviruses       Date:  2016-12-16       Impact factor: 1.723

3.  Lack of adaptation to human tetherin in HIV-1 group O and P.

Authors:  Su Jung Yang; Lisa A Lopez; Colin M Exline; Kevin G Haworth; Paula M Cannon
Journal:  Retrovirology       Date:  2011-09-28       Impact factor: 4.602

4.  The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.

Authors:  Marie Leoz; Felix Feyertag; Anfumbom Kfutwah; Philippe Mauclère; Guillaume Lachenal; Florence Damond; Fabienne De Oliveira; Véronique Lemée; François Simon; David L Robertson; Jean-Christophe Plantier
Journal:  PLoS Pathog       Date:  2015-08-04       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.